The onset of rocuronium, but not of vecuronium or mivacurium, is modified by tourniquet inflation

Anesthesia and Analgesia

Volumn 82, Issue 4, 1996, Pages 848-853

  Audibert, Gérard ^a   Donati, François ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; FENTANYL; MIVACURIUM; NEUROMUSCULAR BLOCKING AGENT; NITROUS OXIDE; ROCURONIUM; THIOPENTAL; VECURONIUM;

ADOLESCENT; ADULT; ANESTHESIA MECHANISM; ARM BLOOD FLOW; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG POTENCY; ELECTROMYOGRAM; FEMALE; HAND MUSCLE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUROMUSCULAR BLOCKING; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TOURNIQUET;

EID: 0029879497     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199604000-00030     Document Type: Article

References (25)

1. Hennis PJ, Stanski DR. Pharmacokinetic and pharmacodynamic factors that govern the clinical use of muscle relaxants. Semin Anesth 1985;4:21-30.
2. Donati F. Onset of action of relaxants. Can J Anaesth 1988;35: S52-S58.
3. Goat VA, Yeung ML, Blakeney C, Feldman SA. The effect of blood flow upon the activity of gallamine triethiodide. Br J Anaesth 1976;48:69-73.
4. Audibert G, Donati F. Tourniquet inflation does not prevent vecuronium action on the arm. Br J Anaesth 1995;74 (Suppl): A288.
5. Paton WDM, Waud DR. The margin of safety of neuromuscular transmission. J Physiol 1967;191:59-90.
6. Donati F, Bevan DR. Muscle electromechanical correlations during succinylcholine infusion. Anesth Analg 1984;63:891-4.
7. Curran MJ, Donati F, Bevan DR. Onset and recovery of atracurium and suxamethonium-induced neuromuscular blockade with simultaneous train-of-four and single twitch stimulation. Br J Anaesth 1987;59:989-94.
8. McCoy EP, Mirakhur RK, Connolly FM, Loan PB. The influence of the duration of contol stimulation on the onset and recovery of neuromuscular block. Anesth Analg 1995;80:364-7.
9. Feldman SA, Soni N, Kraayenbrink MA. Effect of rate of injection on the neuromuscular block produced by vecuronium. Anesth Analg 1989;69:624-6.
10. Wierda JMKH, De Witt APM, Kuizenga K, Agoston S. Clinical observations of the neuromuscular blocking action of Org 9426, a new steroidal non-depolarizing agent. Br J Anaesth 1990;64: 521-3.
11. Wierda JMKH, Kleef UW, Lambalk LM, et al. The pharmacodynamics and pharmacokinetics of Org 9426, a new non-depolarizing blocking agent, in patients anaesthetized with nitrous oxide, halothane and fentanyl. Can J Anaesth 1991;8:430-5.
12. Foldes FF, Nagashima H, Nguyen HD, et al. The neuromuscular effects of Org 9426 in patients receiving balanced anesthesia. Anesthesiology 1991;75:191-6.
13. Cooper R, Mirakhur RK, Clarke RSJ, Boules Z. Comparison of intubating conditions after administration of Org 9426 (rocuronium) and suxamethonium. Br J Anaesth 1992;69:269-73.
14. Oris B, Crul JF, Vandermeersch E, et al. Muscle paralysis by rocuronium during halothane, enflurane, isoflurane and total intravenous anesthesia. Anesth Analg 1993;77:570-3.
15. Bevan DR, Fiset P, Balendran P, et al. Pharmacodynamic behaviour of rocuronium in the elderly. Can J Anaesth 1992;40:127-32.
16. Cantineau JP, Porte F, d'Honneur G, Duvaldestin P. Neuromuscular effects of rocuronium on the diaphragm and adductor pollicis muscles in anesthetized patients. Anesthesiology 1994; 81:585-90.
17. Savarese JJ, Miller RD, Lien CA, Caldwell JE. Pharmacology of muscle relaxants and their antagonists. In: Miller RD, ed. Anesthesia. New York: Churchill Livingstone, 1994:417-87.
18. Diefenbach C, Mellinghoff H, Lynch J, Buzello W. Mivacurium: dose-response relationship and administration by repeated injection or infusion. Anesth Analg 1992;74:420-3.
19. Lien CA, Schmith VD, Embree PB, et al. The pharmacokinetics and pharmacodynamics of the stereoisomers of mivacurium in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Anesthesiology 1994;80:1296-1302.
20. Gariepy LP, Varin F, Donati F, et al. Influence of aging on the pharmacokinetics and pharmacodynamics of doxacurium. Clin Pharmacol Ther 1993;53:340-7.
21. Ducharme J, Varin F, Bevan DR, Donati F. Importance of early blood sampling on vecuronium pharmacokinetic and pharmacodynamic parameters. Clin Pharmacokinet 1993;24:507-18.
22. Goudsouzian NG, d'Hollander AA, Viby-Mogensen J. Prolonged neuromuscular block from mivacurium in two patients with cholinesterase deficiency. Anesth Analg 1993;77:183-5.
23. Bowman WC, Rodger IW, Houston J, et al. Structureaction relationship among some desacetoxy analogues of pancuronium and vecuronium in the anesthetized cat. Anesthesiology 1988;69:57-62.
24. Kopman AF. Pancuronium, gallamine, and d-tubocurarine compared: is speed of onset inversely related to drug potency? Anesthesiology 1989;70:915-20.
25. Law-Min JC, Bekevac I, Glavinovic MI, et al. Iontophoretic study of speed of action of various muscle relaxants. Anesthesiology 1992;77:351-6.